Similar articles

• Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.

  Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW. Doi H, et al. JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005. JACC Cardiovasc Interv. 2009. PMID: 20129555
• Intravascular ultrasound for assessment of coronary drug-eluting stent deployment: an evolving field in need of new criteria.

  Eshtehardi P, Samady H. Eshtehardi P, et al. JACC Cardiovasc Interv. 2010 Mar;3(3):364. doi: 10.1016/j.jcin.2010.01.008. JACC Cardiovasc Interv. 2010. PMID: 20299000 No abstract available.
• Nevo stent: a successful stent makeover.

  Belardi JA. Belardi JA. Catheter Cardiovasc Interv. 2011 Jan 1;77(1):52-3. doi: 10.1002/ccd.22921. Catheter Cardiovasc Interv. 2011. PMID: 21181969 No abstract available.
• Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.

  Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Pichard AD, Waksman R. Bonello L, et al. Arch Cardiovasc Dis. 2009 Feb;102(2):143-51. doi: 10.1016/j.acvd.2008.11.002. Epub 2009 Feb 7. Arch Cardiovasc Dis. 2009. PMID: 19303582 Review.
• Bifurcation disease: what do we know, what should we do?

  Latib A, Colombo A. Latib A, et al. JACC Cardiovasc Interv. 2008 Jun;1(3):218-26. doi: 10.1016/j.jcin.2007.12.008. JACC Cardiovasc Interv. 2008. PMID: 19463303 Review.